Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Our buccal peptide strips are carefully formulated to ensure you get the best possible results
Abstract Antimicrobial resistance (AMR) poses a critical global health challenge
Phase 1a: First-in-Human Single Ascending Dose Study (NCT02951806) Study Title: "Safety, Tolerability, and Pharmacokinetics of Single Doses of Cagrilintide in Healthy Subjects" Status: Completed Phase: Phase 1a Enrollment: 48 healthy volunteers Study Period: 2016-2017 Location: Single center (Denmark) Design: Randomized, double-blind, placebo-controlled, single ascending dose Dose Range: 0.03-10 mg SC Primary Endpoints: Safety, tolerability, PK parameters Population: Healthy male subjects, BMI 20-28 Key Results: Pharmacokinetics: Terminal half-life 5-7 days across dose range
Join LAC Club Usual S$62.50 SGD 62.50 VIP 30% off 1 st & 2 nd item, 50% off 3 rd & 4 th item [Apply code: AUG3050 ] Limited to 1 set per member Valid for member only, till 31 Members must purchase minimum 2 items to enjoy 30% off 1st & 2nd item and choose to forgo 50% off 3rd & 4th item
2020;6:eaax6328
Therefore, with a well selected population that would diminish the 95% confidence interval of relative risk of cardiovascular disease, we suggest that there might be an increased cardiovascular risk in the MTHFR TT mutants when folate status is low
